| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |